1. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
2. Ryan EA, Lakey JRT, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710-719.
3. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-1394.
4. Zulewski H, Abraham EJ, Gerlach MJ, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine and hepatic pheno-types. Diabetes 2001;50:521-533.
5. Lefebvre VH, Otonkoski T, Ustinov J, Huotari M-A, Pipeleers DG, Bouwens L. Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for P-cells. Diabetes 1998;47:134-137.
6. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of ß-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 1995;44:249-256.
7. Bonner-Weir S. Postnatal pancreatic beta cell growth. Endocrinology 2000;141:1926-1929.
8. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000;49:1325-1333.
9. Garcia-Ocana A, Takane K, Syed MA, Vasavada RC, Stewart AF. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation and induces hypoglycemia. J Biol Chem 2000;275:1226-1232.
10. Vasavada RC, Garcia-Ocana A, Zawalich WS, et al. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypo-glycemia. J Biol Chem 2000;275:15,399-15,406.
11. Scaglia L, Smith FE, Bonner-Weir S. Apoptosis contributes to the involution of beta cell mass in post partum rat pancreas. Endocrinology 1995;136:5461-5468.
12. Blume N, Skouv J, Larsson L-I, Holst JJ, Madsen OD. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J Clin Invest 1995;96:2227-2235.
13. Benoist C, Mathis D. Cell death mediators in autoimmune diabetes. Cell 1997;89:1-3.
14. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999;20:501-534.
15. Lee W-H, Bookstein R, Hong F, Young L-J. Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 1987;235:1394-1399.
16. Hanahan D. Heritable formation of pancreatic ß-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115-122.
17. Efrat S. Genetic engineering of beta cells for cell therapy of diabetes: cell growth, function and immunogenicity. Diabetes Rev 1996;4:224-234.
18. Efrat S, Linde S, Kofod H, et al. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 1988;85:9037-9041.
19. Harvey M, Vogel H, Lee EY-P, Bradley A, Donehower LA. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 1995;55:1146-1151.
20. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 1994;7:480-484.
21. Rane S, Dubus P, Mettus RV, et al. Loss of expression of cdk4 causes insulin-deficient diabetes and cdk4 activation results in beta cell hyperplasia. Nat Genet 1999;22:44-52.
22. Tsutsui T, Hesabi B, Moons D, et al. Targeted disruption of cdk4 delays cell cycle entry with enhanced p27-kip activity. Mol Cell Biol 1999;19:7011-7019.
23. Chung DC, Brown SB, Grahme-Cooke F, et al. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab 2000;85:4373-4378.
24. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
25. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
26. Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;88:414-419.
27. Shimomura T, Miyazawa K, Komiyaza Y, et al. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995;229:257-261.
28. Naldini L, Tamagnone L, Vigna E, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992;11:4825-4833.
29. Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993;143:949-958.
30. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993;268:10,024-10,028.
31. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995;129:1177-1180.
32. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem (Tokyo) 1996;119:591-600.
33. Miyazawa T, Kiatmura T, Naka D, Kitamura N. An alternatively processed mRNA generated from human HGF gene. Eur J Biochem 1991;197:15-22.
34. Rubin JS, Chan AM, Bottaro DP, et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of HGF. Proc Natl Acad Sci USA 1991;88:415-419.
35. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-804.
36. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991;49:323-328.
37. Uehara Y, Minowa O, Mori C, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995;373:702-705.
38. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeler C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995;376:768-771.
39. Ptasznik A, Beattie GM, Mally MI, Cirulli V, Lopez A, Hayek A. Phosphatidyl 3-kinase is a negative regulator of cellular differentiation. J Cell Biol 1997;137:1127-1136.
40. Sonnenberg E, Meyer D, Weidner M, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithe-lia during mouse development. J Cell Biol 1993;123:223-235.
41. Calvo EL, Boucher C, Pelletier G, Morisset J. Ontogeny of hepatocyte growth factor and c-met/hgf receptor in rat pancreas. Biochem Biophys Res Commun 1996;229:257-263.
42. Otonkoski T, Cirulli V, Beattie GM, et al. A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic ß-cell growth. Endocrinology 1996;137:3131-3139.
43. Zarnegar R, Muga S, Rahija R, Michalopoulos G. Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA 1990;87:1252-1256.
44. Tsuda H, Iwase T, Matsumoto K, et al. Immunohistochemical localization of hepatocyte growth factor protein in pancreas islet A-cells of man and rats. Jpn J Cancer Res 1992;83:1262-1266.
45. Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao M-S. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 1995;147:889-895.
46. Kristensen P, Nielsen JH, Larsson LI, Dano K. Tissue-type plasminogen activator in somatostatin cells of rat pancreas and hypothalamus. Endocrinology 1987;121:2238-2244.
47. Friess H, Cantero D, Graber H, et al. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology 1997;113:904-913.
48. Vila MR, Nakamura T, Real FX. Hepatocyte growth factor is a potent mitogen for normal human pancreas cells in vitro. Lab Invest 1995;73:409-418.
49. Otonkoski T, Mally MI, Hayek A. Opposite effects of ß-cell differentiation and growth on reg expression in human fetal pancreatic cells. Diabetes 1994;43:1164-1166.
50. Mashima H, Shibata H, Mine T, Kojima I. Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology 1996;137:3969-3976.
51. Menke A, Yamaguchi H, Giehl K, Adler G. Hepatocyte growth factor and fibroblast growth factor 2 are overexpressed after cereulin-induced acute pancreatitis. Pancreas 1999;18:28-33.
52. Otte J-M, Kiehne K, Schmitz F, Fölsch UR, Herzig K-H. C-Met protooncogene expression and its regulation by cytokines in the regenerating pancreas and in pancreatic cancer cells. Scan J Gastroenterol 2000;35:90-95.
53. Otonkoski T, Beattie GM, Rubin JS, Lopez AD, Baird A, Hayek A. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994;43:947-953.
54. Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS. Growth factor/matrix-induced proliferation of human adult ß-cells. Diabetes 1995;44:1458-1460.
55. Nakano M, Yasunami Y, Maki T, et al. Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts. Transplantation 2000;69:214-221.
56. Garcia-Ocana A, Takane KK, Reddy VT, et al. Growth factor expression in mouse islets. J Biol Chem, 2003;278:343-351.
57. Stewart AF, Broadus AE. Malignancy-associated hypercalcemia. In: DeGroot L, Jameson LJ, eds. Endocrinology, 4th ed. WB Saunders, Philadelphia, 2001, pp. 1093-1100.
58. Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med 2000;342:177-185.
59. Wu T, Vasavada R, Yang K, et al. Structural and physiologic characterization of the mid-region secretory form of PTHrP. J Biol Chem 1996;271:24,371-24,381.
60. Philbrick WM, Wysolmerski JJ, Galbraith S, et al. Defining the physiologic roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996;76:127-173.
61. Gaich G, Orloff JJ, Atillasoy EJ, Burtis WJ, Ganz MB, Stewart AF. Amino-terminal parathyroid hormone-related protein: specific binding and cytosolic calcium responses in rat insulinoma cells. Endocrinology 1993;132:1402-1409.
62. Drucker DJ, Asa SL, Henderson J, Goltzman D. The parathyroid hormone-like peptide gene is expressed in the normal and neoplastic human endocrine pancreas. Mol Endocrinol 1989;3:1589-1595.
63. Villanueva-Penacarrillo ML, Cancelas J, de Miguel F, et al. Parathyroid hormone-related protein stimulates DNA sytnhesis and insulin secretion in pancreatic islets. J Endocrinol 1999;163:403-408.
64. Karaplis AC, Luz A, Glowacki J, et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994;8:277-289.
65. Lanske B, Karaplis AC, Lee K, et al. PTH/PTHrP receptor in early development and indian hedgehog-regulated bone growth. Science 1996;273:663-666.
66. Vasavada RC, Cavaliere C, D'Ercole AJ, et al. Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypo-glycemia. J Biol Chem 1996;271:1200-1208.
67. Porter SE, Sorenson RL, Dann P, Garcia-Ocana A, Stewart AF, Vasavada RC. Progressive pancreatic islet hyperplasia in the islet-targeted, parathyroid hormone-related protein-overexpressing mouse. Endocrinology 1998;139:3743-3751.
68. Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 1997;29:301-307.
69. Sorenson RL, Johnson MG, Parsons JA, Sheridan JD. Decreased glucose stimulation threshold, enhanced insulin secretion, and increased beta cell coupling in islets of prolactin-treated rats. Pancreas 1987;2:283-288.
70. Brelje TC, Scharp DW, Lacy PE, et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 1993;132:879-887.
71. Stout LE, Svensson AM, Sorenson RL. Prolactin regulation of islet-derived INS-1 cells: characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 1997;138:1592-1603.
72. Sorenson RL, Stout LE. Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochem-ical analysis. Endocrinology 1995;136:4092-4098.
73. Weinhaus AJ, Stout LE, Sorenson RL. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets. Endocrinology 1996;137:1640-1649.
74. Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 1992;130:1459-1466.
75. Sorenson RL, Brelje TC, Roth C. Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 1993;133:2227-2234.
76. Garcia-Ocana A, Vasavada RC, Takane K, Reddy VT, Batt A, Stewart AF. Transgenic islets overex-pressing hepatocyte growth factor (HGF) demonstrate superior glucose and insulin responses in vitro and in vivo as compared to transgenic PTH-related protein (PTHrP), placental lactogen (PL) and normal islets. Diabetes 2000;49(Suppl 1):A43.
77. Xu G, Stofffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta cell replication and neogenesis, resulting in increased beta cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999;48:2270-2276.
78. Perfetti R, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose intolerant rats. Endocrinology 2000;141:4600-4605.
79. Keiffer TJ, Habener JF, The glucagon-like peptides. Endocr Rev 1999;20:876-913.
80. Stoffers DA, Kieffer TJ, Hussain MA, et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 2000;49:741-748.
81. Baggio L, Adatia F, Troels B, Brubaker PL, Drucker DJ. Sustained expression of exendin-4 does not perturb glucose homeostasis, beta cell mass, or food intake on metallothionine-preproxendin trans-genic mice. J Biol Chem 2000;275:34,471-477.
82. Deacon CF, Danielsen P, Klarskov L, Olesen M, Holst JJ. Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs. Diabetes 2001;50:1588-1597.
83. Flamez D, Gilon P, Moens K, et al. Altered cAMP and Ca2+ signaling in pancreatic islets with glucagon-like peptide-1 receptor null phenotype. Diabetes 1999;48:1979-1986.
84. Young AA, Gedulin BR, Bhavsar S, et al. Glucose-lowering and insulin-sensitizing actions of exendin-4. Diabetes 1999;48:1026-1034.
85. Tourrel C, Bailbe D, Meile M-J, Kergoat M, Portha B. Glucagon-like peptide and exendin-4 stimulate beta cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 2001;50:1562-1570.
86. Kulkarni RN, Burnning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor on beta cells creates and insulin secretory defects similar to that in type 2 diabetes. Cell 1999;96:329-339.
87. Rhodes CJ. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J Mol Endocrinol 2000;24:303-311.
88. Otonkoski T, Beattie GM, Rubin JS, Lopez AD, Baird A, Hayek A. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994;43:947-953.
89. Petrik J, Pell JM, Arany E, et al. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 1999;140:2353-2363.
90. Devedjian JC, George M, Casellas A, et al. Transgenic mice overexpressing insulin-like growth fac-tor-II in beta cells develop type 2 diabetes. J Clin Invest 2000;105:731-740.
91. Kornmann M, Beger HG, Korc M. Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 1998;17:169-175.
92. Arany E, Hill DJ. Ontogeny of fibroblast growth factors in the early development of the rat endocrine pancreas. Pediatr Res 2000;48:389-403.
93. Oberg-Welsh C, Welsh M. Effects of certain growth factors on in vitro maturation of rat fetal islet-like structures. Pancreas 1996;12:334-339.
94. Le Bras S, Miralles F, Basmaciogullari A, Czernichow P, Scharfmann R. Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes 1998;47:1236-1242.
95. Krakowski ML, Kritzik MR, Jones EM, et al. Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells. Am J Pathol 1999;154:683-691.
96. Hart AW, Baeza N, Apelqvist A, Edlund H. Attenuation of FGF signaling in mouse beta cells leads to diabetes. Nature 2000;408:864-888.
97. Terazono K, Yamamoto H, Takasawa S, et al. A novel gene activated in regenerating islets. J Biol Chem 1988;263:2111-2114.
98. Terazono K, Uchiyama Y, Ide M, Watanabe T, Yonekura H, Okamoto H. Expression of reg protein in rat generating islets and its co-localization with insulin in the beta-cell secretory granules. Diabetolo-gia 1990;33:250-252.
99. Stewart TA. The human reg gene encodes pancreatic stone protein. Biochem J 1989;260:622-623.
100. Rouquier S, Giorgi D, Iovanna J, Dagorn J-C. Sequence similarity between the reg transcript and pancreatic stone protein mRNA. Biochem J 1989;264:621-624.
101. Watanabe T, Yonekura H, Tarazono K, Yamamoto H, Okamoto H. Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues: the reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 1990;265:7432-7439.
102. Unno M, Yonekura H, Nakagawara K, et al. Structure, chromosomal localization, and expression of mouse reg genes, reg I and reg II. A novel type of Reg gene, Reg II, exists in the mouse genome. J Biol Chem 1993;268:15,974-15,982.
103. Narushima Y, Unno M, Nakagawara K, et al. Structure, chromosomal localization and expression of mouse genes encoding type III Reg, Reg IIIa, Reg IIIß, Reg IIIy. Gene 1997;185:159-168.
104. Miyashita H, Nakagawara K, Mori M, et al. Human REG family genes are tandemly ordered in a 95-kilobase region of chromosome 2p12. FEBS Lett 1995;377:429-433.
105. Kobayashi S, Akiyama T, Nata K, et al. Identification of a receptor for Reg (regenerating gene) protein, a pancreatic ß-cell regenerating factor. J Biol Chem 2000;275:10,723-10,726.
106. Watanabe T, Yonemura Y, Yonekura H, et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA 1994;91:3589-3592.
107. Gross DJ, Weiss L, Reibstein I, et al. Amelioration of diabetes in NOD mice with advanced disease by Linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 1998;139:2369-2374.
108. Okamoto H. The role of Reg genes: genetic introduction of human REG I and/or administration of REG I product may be effective in the prevention and cure of diabetes in man. Exp Clin Endocrinol Diabetes 1997;105:A12-A13.
109. Okamoto H. The reg gene family and reg proteins: with special attention to the regeneration of pancreatic beta cells. J Hepatobiliary Pancreat Surg 1999;6:254-262.
110. Rafaeloff R, Pittenger GL, Barlow SW, et al. Cloning and expression of the pancreatic islet neogene-sis-associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest 1997;99:2100-2109.
111. Watanabe T, Shintani A, Nakata M, et al. Recombinant human betacellulin. Molecular structure, biological activities and receptor interaction. J Biol Chem 1994;269:9966-9973.
112. Shing Y, Christofori G, Hanahan D, et al. Betacellulin: a mitogen from pancreatic ß-cell tumors. Science 1993;259:1604-1607.
113. Sasada R, Ono Y, Taniyama Y, Shing Y, Folkman J, Igarashi K. Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem Biophys Res Commun 1993;190:1173-1179.
114. Groenen LC, Nice EC, Burgess AW. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 1994;11:235-257.
115. Riese DJ, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-ß. Oncogene 1996;12:345-353.
116. Huotari M, Palgi J, Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel ß-cell mitogen. Endocrinology 1998;139:1494-1499.
117. Mashima H, Ohnishi H, Wakabayashi K, et al. Betacellulin and activin A coordinately convert amy-lase-secreting pancreatic AR42J cells into insulin-secreting cells. J Clin Invest 1996;97:1647-1654.
118. Watada H, Kajimoto Y, Miyagawa J, et al. PDX-1 induces insulin and glucokinase gene expressions in aTC1 clone 6 cells in the presence of betacellulin. Diabetes 1996;45:1826-1831.
119. Yamamoto K, Miyagawa J-I, Waguri M, et al. Recombinant human betacellulin promotes neogenesis of beta cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes 2000;49:2021-2027.
120. Eric P. Sandgren, Noreen C, et al. Overexpression of TGFa in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990;61:1121-1135.
121. Jhappan C, Stahle C, Harkins RN, et al. TGFa overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-1146.
122. Brand SJ, Fuller PJ. Differential gastrin Gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 1988;263:5341-5347.
123. Wang TC, Koh TJ, Varro A, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996;98:1918-1929.
124. Wang TC, Bonner-Weir S, Oates PS, et al. Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest 1993;92:1349-1356.
125. Ebert M, Kasper HU, Hernberg S, et al. Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis. Dig Dis Sci 1998;43:567-574.
126. Welsh M, Claesson-Welsh L, Hallberg A, et al. Coexpression of the platelet-derived growth factor (PDGF) B chain and the PDGF ß receptor in isolated pancreatic islet cells stimulates DNA synthesis. Proc Natl Acad Sci USA 1990;87:5807-5811.
127. Swenne I, Heldin CH, Hill DJ, Hellerstrom C. Effects of platelet-derived growth factor and somatomedin-C/insulin-like growth factor I on the deoxyribonucleic acid replication of fetal rat islets of Langerhans in tissue culture. Endocrinology 1988;122:214-218.
128. Kanaka-Gantenbein C, Dicou E, Czernichow P, Scharfmann R. Presence of nerve growth factor and its receptors in an in vitro model of islet cell development: implications for normal islet morphogenesis. Endocrinology 1995;136:3154-3162.
129. Rosenbaum T, Sanchez-Soto MC, Hiriart M. Nerve growth factor increases insulin secretion and barium current in pancreatic beta cells. Diabetes 2001;50:1755-1756.
130. Boyd AE. The nerve of them beta cells and nerve growth factor. Endocrinology 1994;134:2319-2320.
Was this article helpful?
All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.